The DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.
Apolipoprotein E: Far More Than a Lipid Transport Protein
Abstract
First recognized as a major determinant in lipoprotein metabolism and cardiovascular disease, apolipoprotein (apo) E has emerged as an important molecule in several biological processes not directly related to its lipid transport function, including Alzheimer's disease and cognitive function, immunoregulation, and possibly even infectious diseases. ApoE is a polymorphic protein arising from three alleles at a single gene locus. The three major isoforms, apoE4, apoE3, and apoE2, differ from one another only by single amino acid substitutions, yet these changes have profound functional consequences at both the cellular and molecular levels. ApoE3 seems to be the normal isoform in all known functions, while apoE4 and apoE2 can each be dysfunctional. Isoform (allele)-specific effects include the association of apoE2 with the genetic disorder type III hyperlipoproteinemia and with both increased and decreased risk for atherosclerosis and the association of apoE4 with increased risk for both atherosclerosis and Alzheimer's disease, impaired cognitive function, and reduced neurite outgrowth; isoform-specific differences in cellular signaling events may also exist. Functional differences in the apoE isoforms that affect (or did affect) survival before the reproductive years probably account, at least in part, for the allele frequencies of the present day.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Exchangeable apolipoproteins are typically consisting of two functional domains: lipid-binding domain and receptor-binding domain24.”
From Brain-targeted drug delivery by manipulating protein corona functions (2019) · cites this paper as [24]
In the citing paper
“However, these striking vasculotropic effects observed here in APP/ε2 mice may not be robustly seen in human subjects, where ε2 homozygotes constitute only 1% of the population, with less than 10% of them developing type III hyperlipoproteinemia, what is linked to distinctly different contribution of apoE to VLDL formation between humans and mice [62].”
From APOE Genotype Differentially Modulates Effects of Anti-Aβ, Passive Immunization in APP Transgenic Mice (2017) · cites this paper as [62]
In the citing paper
“By contrast, APOE4 has increased binding affinity (up to two-fold) for heparin and HSPG over APOE3 (refs. 32–35).”
From The APOE-R136S mutation protects against APOE4-driven tau pathology, neurodegeneration, and neuroinflammation (2023) · cites this paper as [32]
In the citing paper
“As serum apoE plays its role in lipid metabolism through the LDL receptor, the HSPG and LDL receptor‐related protein (LRP) pathway (Mahley & Rall Jr., 2000), mutations could alter the configuration of the APOE protein and further impact its binding ability to LDL receptor, which could explain the formation of lipoprotein thrombi in the glomerulus.”
From Clinical and genetic analysis of lipoprotein glomerulopathy patients caused by APOE mutations (2020) · cites this paper as Mahley & Rall Jr., 2000
In the citing paper
“Human apoE is a protein consisting of 299 amino acid residues with a molecular weight of 34 kDa8).”
From Impact of Apolipoprotein E Variants: A Review of Naturally Occurring Variants and Clinical Features (2025) · cites this paper as [8]
In the citing paper
“ε3 has Cys112 and Arg158, while ε4 (Cys112Arg, p.Cys130Arg) has arginine at both positions and ε2 (Arg158Cys, p.Arg176Cys) has cysteine at both positions (Fig.3)8).”
From Impact of Apolipoprotein E Variants: A Review of Naturally Occurring Variants and Clinical Features (2025) · cites this paper as [8]
In the citing paper
“apoE on triglyceride-rich lipoproteins binds to the LDL receptor (LDLR), the LDLR-related protein 1 (LRP1), and heparan sulfate proteoglycans (HSPGs) ( 3,4 ).”
From Macrophage-derived apoESendai suppresses atherosclerosis while causing lipoprotein glomerulopathy in hyperlipidemic mice (2014) · cites this paper as [4]
In the citing paper
“Despite the presence of several receptors that are capable of internalizing apoE such as low-density lipoprotein receptor (LDLR), LDLR-related protein (LRP), apoER2, and VLDLR, in neurons apoE is mostly imported via the LDLR [12]–[15].”
From LDLR Expression and Localization Are Altered in Mouse and Human Cell Culture Models of Alzheimer's Disease (2010) · cites this paper as [13]
In the citing paper
“APOE ε4 (E4) is a major genetic risk factor for cardiovascular disease (CVD) and Alzheimer's disease (AD).”
From Apolipoprotein E–low density lipoprotein receptor interaction affects spatial memory retention and brain ApoE levels in an isoform-dependent manner (2014) · cites this paper as Mahley and Rall, 2000
In the citing paper
“Apolipoprotein E (apoE) is a critical ligand for high-affinity binding of remnant lipoproteins to members of the low density lipoprotein receptor (LDLR) family and HSPG (5–7).”
From Role of the N- and C-Terminal Domains in Binding of Apolipoprotein E Isoforms to Heparan Sulfate and Dermatan Sulfate: A Surface Plasmon Resonance Study (2008) · cites this paper as [7]
In the citing paper
“Thus, besides being a risk factor for Alzheimer’s disease, apoE4 is associated with an increased risk for coronary heart disease (7).”
From Role of the N- and C-Terminal Domains in Binding of Apolipoprotein E Isoforms to Heparan Sulfate and Dermatan Sulfate: A Surface Plasmon Resonance Study (2008) · cites this paper as [7]
Citations
Cites
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology
Mahley, R. W. (1988) · Science · doi:10.1126/science.3283935 · Cited by 4,028
Self-citationLIPOPROTEIN METABOLISM IN THE MACROPHAGE: Implications for Cholesterol Deposition in Atherosclerosis
Brown, M. S., & Goldstein, J. L. (1983) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.52.070183.001255 · Cited by 2,300
Apolipoprotein E polymorphism and atherosclerosis.
Davignon, J., Gregg, R. E., & Sing, C. F. (1988) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.8.1.1 · Cited by 1,981
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
Fredrickson, D. S., Levy, R. I., & Lees, R. S. (1967) · New England Journal of Medicine · doi:10.1056/nejm196701052760107 · Cited by 1,911
ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree.
Nakashima, Y., Plump, A. S., Raines, E. W., Breslow, J. L., & Ross, R. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.1.133 · Cited by 1,693
Strittmatter, W. J., Weisgraber, K. H., Huang, D. Y., Dong, L. M., Salvesen, G. S., Pericak-Vance, M., Schmechel, D., Saunders, A. M., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.8098 · Cited by 1,363
Hiesberger, T., Trommsdorff, M., Howell, B. W., Goffinet, A., Mumby, M. C., Cooper, J. A., & Herz, J. (1999) · Neuron · doi:10.1016/s0896-6273(00)80861-2 · Cited by 916
Ma, J., Yee, A., Brewer, H. B., Das, S., & Potter, H. (1994) · Nature · doi:10.1038/372092a0 · Cited by 871
Apolipoprotein E: Structure-Function Relationships
Weisgraber, K. H. (1994) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60642-7 · Cited by 830
Reelin Is a Ligand for Lipoprotein Receptors
D'Arcangelo, G., Homayouni, R., Keshvara, L., Rice, D. S., Sheldon, M., & Curran, T. (1999) · Neuron · doi:10.1016/s0896-6273(00)80860-0 · Cited by 808
Differential Effects of Apolipoproteins E3 and E4 on Neuronal Growth in Vitro
Nathan, B. P., Bellosta, S., Sanan, D. A., Weisgraber, K. H., Mahley, R. W., & Pitas, R. E. (1994) · Science · doi:10.1126/science.8171342 · Cited by 795
Self-citationLipoprotein receptors and cholesterol homeostasis
Mahley, R. W., & Innerarity, T. L. (1983) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(83)90001-1 · Cited by 756
Self-citationHuman apolipoprotein E. The complete amino acid sequence
Rall, S. C., Weisgraber, K. H., & Mahley, R. W. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34702-1 · Cited by 741
Self-citationMiyata, M., & Smith, J. D. (1996) · Nature Genetics · doi:10.1038/ng0996-55 · Cited by 735
(1985) · PubMed · Cited by 706
Mahley, R. W., & Ji, Z.-S. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33334-4 · Cited by 693
Self-citationThree-Dimensional Structure of the LDL Receptor-Binding Domain of Human Apolipoprotein E
Wilson, C., Wardell, M. R., Weisgraber, K. H., Mahley, R. W., & Agard, D. A. (1991) · Science · doi:10.1126/science.2063194 · Cited by 678
Self-citationWeisgraber, K. H., Innerarity, T. L., & Mahley, R. W. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34954-8 · Cited by 673
Self-citationHerpes simplex virus type 1 in brain and risk of Alzheimer's disease
Itzhaki, R. F., Lin, W., Shang, D., Wilcock, G. K., Faragher, B. E., & Jamieson, G. A. (1997) · The Lancet · doi:10.1016/s0140-6736(96)10149-5 · Cited by 671
Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man
UTERMANN, G., HEES, M., & STEINMETZ, A. (1977) · Nature · doi:10.1038/269604a0 · Cited by 666
Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression
Reddick, R. L., Zhang, S. H., & Maeda, N. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.1.141 · Cited by 633
Zannis, V. I., & Breslow, J. L. (1981) · Biochemistry · doi:10.1021/bi00507a059 · Cited by 563
Isoform-specific binding of apolipoprotein E to beta-amyloid.
LaDu, M. J., Falduto, M. T., Manelli, A. M., Reardon, C. A., Getz, G. S., & Frail, D. E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31529-6 · Cited by 540
Hepatic uptake of chylomicron remnants
Cooper, A. D. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34932-4 · Cited by 499
Strittmatter, W. J., Saunders, A. M., Goedert, M., Weisgraber, K. H., Dong, L. M., Jakes, R., Huang, D. Y., Pericak-Vance, M., Schmechel, D., & Roses, A. D. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.11183 · Cited by 474
Trommsdorff, M., Borg, J.-P., Margolis, B., & Herz, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.50.33556 · Cited by 453
Mahley, R. W., Huang, Y., & Rall, S. C. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32417-2 · Cited by 447
Self-citationModulation of plasma triglyceride levels by apoE phenotype: a meta-analysis.
Dallongeville, J., Lussier‐Cacan, S., & Davignon, J. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41611-6 · Cited by 444
Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro.
(1994) · PubMed Central · Cited by 441
Proposed nomenclature of apoE isoproteins, apoE genotypes, and phenotypes
Zannis, V. I., Breslow, J. L., Utermann, G., Mahley, R. W., Weisgraber, K. H., Havel, R. J., Goldstein, J. L., Brown, M. S., Schonfeld, G., Hazzard, W. R., et al. (1982) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38094-9 · Cited by 436
Self-citationDietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E.
Weintraub, M. S., Eisenberg, S., & Breslow, J. L. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113243 · Cited by 418
Sanan, D. A., Weisgraber, K. H., Russell, S. J., Mahley, R. W., Huang, D., Saunders, A., Schmechel, D., Wisniewski, T., Frangione, B., & Roses, A. D. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117407 · Cited by 404
Self-citationKounnas, M. Z., Moir, R. D., Rebeck, G. W., Bush, A. I., Argraves, W. S., Tanzi, R. E., Hyman, B. T., & Strickland, D. K. (1995) · Cell · doi:10.1016/0092-8674(95)90320-8 · Cited by 401
Raber, J., Wong, D., Buttini, M., Orth, M., Bellosta, S., Pitas, R. E., Mahley, R. W., & Mucke, L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10914 · Cited by 364
Self-citationButtini, M., Orth, M., Bellosta, S., Akeefe, H., Pitas, R. E., Wyss‐Coray, T., Mucke, L., & Mahley, R. W. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-12-04867.1999 · Cited by 363
Self-citationHoltzman, D. M., Pitas, R. E., Kilbridge, J., Nathan, B., Mahley, R. W., Bu, G., & Schwartz, A. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.21.9480 · Cited by 349
Self-citationAbnormal in vivo metabolism of apolipoprotein E4 in humans.
Gregg, R. E., Zech, L. A., Schaefer, E. J., Stark, D., Wilson, D., & Brewer, H. B. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112645 · Cited by 345
Apolipoprotein E polymorphism and coronary artery disease.
Menzel, H. J., Kladetzky, R. G., & Assmann, G. (1983) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.3.4.310 · Cited by 344
(1981) · PubMed · Cited by 341
Human apolipoprotein E: the Alzheimer's disease connection
Weisgraber, K. H., & Mahley, R. W. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.13.8940294 · Cited by 333
Self-citationDong, L. M., Wilson, C., Wardell, M. R., Simmons, T., Mahley, R. W., Weisgraber, K. H., & Agard, D. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31797-0 · Cited by 320
Self-citationApolipoprotein E epsilon4 and the risk of dementia with stroke. A population-based investigation
Slooter, A. J. C. (1997) · JAMA · doi:10.1001/jama.277.10.818 · Cited by 320
Human Apolipoprotein E4 Domain Interaction
Dong, L.-M., & Weisgraber, K. H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19053 · Cited by 318
Bellosta, S., Nathan, B. P., Orth, M., Dong, L.-M., Mahley, R. W., & Pitas, R. E. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.27063 · Cited by 313
Self-citationSchneider, W. J., Kovanen, P. T., Brown, M. S., Goldstein, J. L., Utermann, G., Weber, W., Havel, R. J., Kotite, L., Kane, J. P., Innerarity, T. L., et al. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110330 · Cited by 310
Self-citationApolipoprotein E: from atherosclerosis to Alzheimerʼs disease and beyond
Mahley, R. W., & Huang, Y. (1999) · Current Opinion in Lipidology · doi:10.1097/00041433-199906000-00003 · Cited by 308
Self-citationIncreased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages
Fazio, S., Babaev, V. R., Murray, A. B., Hasty, A. H., Carter, K. J., Gleaves, L. A., Atkinson, J. B., & Linton, M. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4647 · Cited by 295
Human apolipoprotein E3 in aqueous solution. I. Evidence for two structural domains.
Wetterau, J. R., Aggerbeck, L. P., Rall, S. C., & Weisgraber, K. H. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68778-2 · Cited by 293
Self-citationBellosta, S., Mahley, R. W., Sanan, D. A., Murata, J., Newland, D. L., Taylor, J. M., & Pitas, R. E. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118271 · Cited by 284
Self-citationNathan, B. P., Chang, K.-C., Bellosta, S., Brisch, E., Ge, N., Mahley, R. W., & Pitas, R. E. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.34.19791 · Cited by 276
Self-citationGenetics of the apolipoprotein E system in man.
Utermann, G., Langenbeck, U., Beisiegel†, U., & Weber, W. T. (1980) · Europe PMC (PubMed Central) · Cited by 264
Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice.
van Vlijmen, B. J. M., van den Maagdenberg, A. M. J. M., Gijbels, M. J., van der Boom, H., HogenEsch, H., Frants, R. R., Hofker, M. H., & Havekes, L. M. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117117 · Cited by 250
Apolipoprotein E phenotypes and hyperlipidemia
Utermann, G., Kindermann, I., Kaffarnik, H., & Steinmetz, A. (1984) · Human Genetics · doi:10.1007/bf00286508 · Cited by 238
Aggerbeck, L. P., Wetterau, J. R., Weisgraber, K. H., Wu, C. S., & Lindgren, F. T. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68779-4 · Cited by 229
Stengård, J., Zerba, K. E., Pekkanen, J., Ehnholm, C., Nissinen, A. M., & Sing, C. F. (1995) · Circulation · doi:10.1161/01.cir.91.2.265 · Cited by 224
Sun, Y., Wu, S., Bu, G., Onifade, M. K., Patel, S. N., LaDu, M. J., Fagan, A. M., & Holtzman, D. M. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-09-03261.1998 · Cited by 213
de Bont, N., Netea, M. G., Demacker, P. N. M., Verschueren, I., Kullberg, B. J., van Dijk, K. W., van der Meer, J. W. M., & Stalenhoef, A. F. H. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32147-7 · Cited by 210
The evolution of Alzheimer disease, the reproductive schedule, and apoE isoforms☆
Finch, C. E., & Sapolsky, R. M. (1999) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00053-6 · Cited by 208
Netea, M. G., Demacker, P. N. M., Kullberg, B. J., Boerman, O. C., Verschueren, I., Stalenhoef, A. F. H., & van der Meer, J. W. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118556 · Cited by 207
Apolipoprotein E and cognitive change in an elderly population
Hyman, B. T., Gómez‐Isla, T., Briggs, M. E., Chung, H., Nichols, S., Kohout, F. J., & Wallace, R. B. (1996) · Annals of Neurology · doi:10.1002/ana.410400111 · Cited by 205
Overexpression and Accumulation of Apolipoprotein E as a Cause of Hypertriglyceridemia
Huang, Y., Liu, X. Q., Rall, S. C., Taylor, J. M., von Eckardstein, A., Assmann, G., & Mahley, R. W. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.41.26388 · Cited by 204
Self-citationHan, S.-H., Einstein, G., Weisgraber, K. H., Strittmatter, W. J., Saunders, A. M., Pericak-Vance, M., Roses, A. D., & Schmechel, D. E. (1994) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199409000-00013 · Cited by 195
Roselaar, S. E., & Daugherty, A. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32160-x · Cited by 193
Marinetti, G. V. (1990) · Springer eBooks · doi:10.1007/978-1-4615-9564-9 · Cited by 188
Curtiss, L. K., & Edgington, T. S. (1976) · The Journal of Immunology · doi:10.4049/jimmunol.116.5.1452 · Cited by 186
Huang, Y., von Eckardstein, A., Wu, S., Maeda, N., & Assmann, G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.5.1834 · Cited by 180
Innerarity, T. L., Weisgraber, K. H., Arnold, K. S., Rall, S. C., & Mahley, R. W. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39866-6 · Cited by 179
Self-citationThe role of apolipoprotein E genetic variants in lipoprotein disorders.
RALL, S. C., & MAHLEY, R. W. (1992) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1992.tb01254.x · Cited by 150
Self-citationGlycosylation of Human Apolipoprotein E
Wernette-Hammond, M. E., Lauer, S. J., Corsini, A., Walker, D., Taylor, J. M., & Rall, S. C. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)81907-x · Cited by 149
Self-citationUtermann, G., Steinmetz, A., & Weber, W. (1982) · Human Genetics · doi:10.1007/bf00569216 · Cited by 149
Ishigami, M., Swertfeger, D. K., Granholm, N. A., & Hui, D. Y. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20156 · Cited by 144
Rensen, P. C. N., & van Berkel, T. J. C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.25.14791 · Cited by 144
Apolipoprotein E Isoform-Specific Differences in Outcome from Focal Ischemia in Transgenic Mice
Sheng, H., Laskowitz, D. T., Bennett, E. R., Schmechel, D. E., Bart, R. D., Saunders, A. M., Pearlstein, R. D., Roses, A. D., & Warner, D. S. (1998) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199804000-00003 · Cited by 143
Ji, Z.-S., Pitas, R. E., & Mahley, R. W. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13452 · Cited by 134
Self-citationKelly, M. E., Clay, M. A., Mistry, M. J., Hsieh-Li, H.-M., & Harmony, J. A. K. (1994) · Cellular Immunology · doi:10.1006/cimm.1994.1302 · Cited by 131
Novel mechanism for defective receptor binding of apolipoprotein E2 in type III hyperlipoproteinemia
Dong, L., Parkin, S., Trakhanov, S. D., Rupp, B., Simmons, T., Arnold, K. S., Newhouse, Y. M., Innerarity, T. L., & Weisgraber, K. H. (1996) · Nature Structural & Molecular Biology · doi:10.1038/nsb0896-718 · Cited by 129
Hanlon, C. (1995) · Atherosclerosis · doi:10.1016/0021-9150(94)05402-5 · Cited by 129
Immunoregulatory plasma lipoproteins. Role of apoprotein E and apoprotein B.
Hui, D. Y., Harmony, J. A. K., Innerarity, T. L., & Mahley, R. W. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)70201-4 · Cited by 125
Self-citationDeMattos, R. B., Curtiss, L. K., & Williams, D. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.7.4206 · Cited by 123
Preclinical memory decline in cognitively normal apolipoprotein E–ε4 homozygotes
Caselli, R. J., Graff‐Radford, N. R., Reiman, E. M., Weaver, A., Osborne, D., Lucas, J. A., Uecker, A., & Thibodeau, S. N. (1999) · Neurology · doi:10.1212/wnl.53.1.201 · Cited by 120
Owens, B. J., Anantharamaiah, G. M., Kahlon, J. B., Srinivas, R. V., Compans, R. W., & Segrest, J. P. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114819 · Cited by 110
Bergeron, N., & Havel, R. J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118408 · Cited by 100
Salt bridge relay triggers defective LDL receptor binding by a mutant apolipoprotein.
Wilson, C., Mau, T., Weisgraber, K. H., Wardell, M. R., Mahley, R. W., & Agard, D. A. (1994) · Structure · doi:10.1016/s0969-2126(00)00072-1 · Cited by 100
Self-citationRemnant lipoproteins inhibit malaria sporozoite invasion of hepatocytes.
Sinnis, P., Willnow, T. E., Briones, M. R. S., Herz, J., & Nussenzweig, V. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.3.945 · Cited by 97
Amyloid β‐Protein, APOE Genotype and Head Injury
Nicoll, J. A. R., Roberts, G. W., & Graham, D. I. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb34431.x · Cited by 96
Association of human, rat, and rabbit apolipoprotein E with ?-amyloid
LaDu, M. J., Lukens, J. R., Reardon, C. A., & Getz, G. S. (1997) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19970701)49:1 · Cited by 92
Huang, Y., Ji, Z.-S., Brecht, W. J., Rall, S. C., Taylor, J. M., & Mahley, R. W. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.12.2952 · Cited by 87
Self-citationHuang, Y., Liu, X., Rall, S. C., & Mahley, R. W. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.28.17483 · Cited by 86
Self-citationArai, T., Rinninger, F., Varban, M. L., Fairchild-Huntress, V., Liang, C.-P., Chen, W., Seo, T., Deckelbaum, R. J., Huszar, D., & Tall, A. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.21.12050 · Cited by 86
Boerwinkle, E., Brown, S. A., Rohrbach, K., Gotto, A. M., & Patsch, W. (1991) · PubMed · Cited by 85
Shakibaei, M., & Frevert, U. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.5.1699 · Cited by 84
Are men carrying the apolipoprotein ε4- or ε2 allele less fertile than ε3ε3 genotypes?
Gerdes, L. U., Gerdes, C., HANSEN, P. S., Klausen, I. C., & Færgeman, O. (1996) · Human Genetics · doi:10.1007/s004390050200 · Cited by 81
The LDL-receptor-related protein ??? portrait of a multifunctional receptor
Herz, J. (1993) · Current Opinion in Lipidology · doi:10.1097/00041433-199304000-00006 · Cited by 77
Memory Self-Appraisal in Middle-Aged and Older Adults With the Apolipoprotein E-4 Allele
Small, G. W., Chen, S. T., Komo, S., Ercoli, L. M., Bookheimer, S. Y., Miller, K., Lavretsky, H., Saxena, S., Kaplan, A. R., Dorsey, D., et al. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.7.1035 · Cited by 76
The apolipoprotein E polymorphism in Greenland Inuit in its global perspective
Gerdes, L. U., Gerdes, C., HANSEN, P. S., Klausen, I. C., Færgeman, O., & Dyerberg, J. (1996) · Human Genetics · doi:10.1007/s004390050257 · Cited by 69
Mahley, R. W., Nathan, B. P., Bellosta, S., & Pitas, R. E. (1995) · Current Opinion in Lipidology · doi:10.1097/00041433-199504000-00005 · Cited by 68
Self-citationLipoproteins, neurobiology, and Alzheimer's disease: structure and function of apolipoprotein E
Weisgraber, K. H., Pitas, R. E., & Mahley, R. W. (1994) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(94)90212-7 · Cited by 58
Self-citationJong, M. C., Dahlmans, V. E. H., van Gorp, P. J., Breuer, M. L., Mol, M. J. T. M., van der Zee, A., Frants, R. R., Hofker, M. H., & Havekes, L. M. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.8.934 · Cited by 57
Apolipoprotein E2 Transgenic Rabbits
Huang, Y., Schwendner, S. W., Rall, S. C., Sanan, D. A., & Mahley, R. W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.36.22685 · Cited by 52
Self-citationFazio, S., Sanan, D. A., Lee, Y. L., Ji, Z. S., Mahley, R. W., & Rall, S. C. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.11.1873 · Cited by 49
Self-citationMajack, R. A., Castle, C. K., Goodman, L. V., Weisgraber, K. H., Mahley, R. W., Shooter, E. M., & Gebicke-Haerter, P. J. (1988) · The Journal of cell biology · doi:10.1083/jcb.107.3.1207 · Cited by 47
Self-citationCuthbert, J. A., & Lipsky, P. E. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111325 · Cited by 46
Only multimers of a synthetic peptide of human apolipoprotein E are biologically active
Dyer, C. A., Smith, R. S., & Curtiss, L. K. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98578-9 · Cited by 41
Cuthbert, J. A., & Lipsky, P. E. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.14.4539 · Cited by 37
Hui, D. Y., & Harmony, J. A. K. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.8.4764 · Cited by 34
Functions of the LDL Receptor Gene Family
Herz, J., & Willnow, T. E. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb44298.x · Cited by 34
Martin, I., Dubois, M.-C., Særmark, T., & Ruysschaert, J. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)80780-6 · Cited by 32
Huang, Y., Rall, S. C., & Mahley, R. W. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.11.2817 · Cited by 31
Self-citationvan Dijk, K. W., van Vlijmen, B. J. M., Hof, H. B. V., van der Zee, A., Santamarina-Fojo, S., van Berkel, T. J. C., Havekes, L. M., & Hofker, M. H. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33374-5 · Cited by 31
Cardin, A. D., Bowlin, T. L., & Krstenansky, J. L. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(88)90202-1 · Cited by 28
Browning, P. J., Roberts, D. D., Zabrenetzky, V. S., Bryant, J., Kaplan, M. P., Washington, R., Panet, A., Gallo, R. C., & Vogel, T. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.180.5.1949 · Cited by 27
SFazio, ASanan, D., LLee, Y., SJi, Z., WMahley, R., & CRall, S. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · Cited by 21
Research works printed but not linked: 10
- Boerwinkle E, 1991, Am. J. Hum. Genet., 49, 1145
- Harmony JAK, Akeson AL, McCarthy BM, Morris RE, Scupham DW, Grupp SA. 1986. Immunoregulation by plasma lipoproteins. In Biochemistry and Biology of Plasma Lipoproteins , ed. AM Scanu, AA Spector, pp. 403–52. New York: Marcel Dekker
- Mahley RW. 1997. Apolipoprotein E: structure and function in lipid metabolism and neurobiology. In The Molecular and Genetic Basis of Neurological Disease , ed. RN Rosenberg, SB Prusiner, S DiMauro, RL Barchi, pp. 1037–49. Boston: Butterworth–Heinemann. 2nd ed.
- Mahley RW, Rall SCJr . 1995. Type III hyperlipoproteinemia (dysbetalipoproteinemia): the role of apolipoprotein E in normal and abnormal lipoprotein metabolism. In The Metabolic and Molecular Bases of Inherited Disease , ed. CR Scriver, AL Beaudet, WS Sly, D Valle, pp. 1953–80. New York: McGraw-Hill. 7th ed.
- Sing CF, 1985, Am. J. Hum. Genet., 37, 268
- 10.1001/jama.1997.03540340052032 · DOI
- Utermann G. 1985. Genetic polymorphism of apolipoprotein E—impact on plasma lipoprotein metabolism. In Diabetes, Obesity and Hyperlipidemias –III, ed. G Crepaldi, A Tiengo, G Baggio, pp. 1–28. Amsterdam: Elsevier Science
- Utermann G, 1980, Am. J. Hum. Genet., 32, 339
- Wisniewski T, 1994, Am. J. Pathol., 145, 1030
- Zannis VI, 1981, Am. J. Hum. Genet., 33, 11
Cited by
Sorted by citations
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Liu, C.-C., Kanekiyo, T., Xu, H., & Bu, G. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.263 · Cited by 3,459
2018 Alzheimer's disease facts and figures
Alzheimer's Association (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.001 · Cited by 1,912
Lipids and Lipid-Based Formulations: Optimizing the Oral Delivery of Lipophilic Drugs
Porter, C. J. H., Trevaskis, N. L., & Charman, W. N. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2197 · Cited by 1,824
The role of apolipoprotein E in Alzheimer's disease
Kim, J., Basak, J. M., & Holtzman, D. M. (2009) · Neuron · doi:10.1016/j.neuron.2009.06.026 · Cited by 1,661
Distinct patterns of brain activity in young carriers of the APOE -ε4 allele
Filippini, N., MacIntosh, B. J., Hough, M. G., Goodwin, G. M., Frisoni, G. B., Smith, S. M., Matthews, P. M., Beckmann, C. F., & Mackay, C. E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811879106 · Cited by 1,613
Metadata
- Authors
- Mahley, R. W., & Rall, S. C.
- Affiliations
- University of California, San Francisco (US)
- ORCID
- Mahley, Robert W.
- Venue
- Annual Review of Genomics and Human Genetics
- Publisher
- Annual Reviews
- Published
- 2000-09
- Volume
- 1
- Issue
- 1
- Pages
- 507-537
- ISSN
- 1527-8204 (ISSN-L)
- 1545-293X
- OpenAlex
- W2121101037
- Cited by
- 1,836
- References
- 114
- Citations by year
- 2026: 54 · 2025: 85 · 2024: 71 · 2023: 55 · 2022: 95 · 2021: 103 · 2020: 70 · 2019: 79 · 2018: 64 · 2017: 80 · 2016: 86 · 2015: 75 · 2014: 100 · 2013: 80 · 2012: 83
- FWCI
- 3.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annual Review of Genomics and Human Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5p01hl047660-10)
- National Heart, Lung, and Blood Institute (HL-47660)
- National Institute of Allergy and Infectious Diseases (R37AI020565)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- apolipoprotein E, apolipoprotein E isoforms, APOE ε4, APOE3, APOE2, APOE polymorphism, Alzheimer's disease, cognitive function, immune regulation, infectious diseases, type III hyperlipoproteinemia, atherosclerosis, cardiovascular disease, neurite outgrowth, allele frequency
- MeSH terms
- Alleles, Animals, Apolipoproteins E, Arteriosclerosis, Biological Transport, Active, Communicable Diseases, Female, Heart Diseases, Humans, Hyperlipoproteinemia Type III, Immunity, Lipoproteins, Male, Models, Molecular, Neurobiology, Phenotype, Polymorphism, Genetic, Reproduction, Risk Factors, Protein Isoforms, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
